Demonstration of the BCR-ABL translocation continues to underpin therapeutic stratification in chronic myeloid leukemia through the use of imatinib and subsequent generations of TKIs. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.